In a study of 61 patients with advanced-stage endometrial cancer with wild-type p53 expression and proficient MMR expression, L1CAM expression (clone UJ127.11, dilution 1:1000, cutoff 10%) was a poor prognostic factor [69]. Here, TP53 is linked to endometrial cancer.